A Jan 2026 110.000 put
| Previous Close | 5.30 |
| Open | 5.30 |
| Bid | 5.20 |
| Ask | 5.50 |
| Strike | 110.00 |
| Expire Date | 2026-01-16 |
| Day's Range | 5.30 - 5.30 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 46 |
Simply Wall St.Those who invested in Agilent Technologies (NYSE:A) five years ago are up 85%
These days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But the truth is...
BloombergThe Stocks, Bonds and Currencies Investors Are Watching During the Trump-Harris Debate
(Bloomberg) -- Investors weighing election risks ahead of the first US presidential debate between Vice President Kamala Harris and former President Donald Trump are already a lot more jittery than they were before Trump and his onetime opponent, President Joe Biden, met onstage in June.Most Read from BloombergHow Americans Voted Their Way Into a Housing CrisisChicago Halts Hiring as Deficit Tops $1 Billion Through 2025After a Record Hot Summer, Pressure Grows for A/C MandatesUC Berkeley Gives T
Business WireAgilent Unveils Biopharma CDx Services Lab to Accelerate Precision Medicine
SANTA CLARA, Calif., September 09, 2024--Agilent Technologies Inc., (NYSE: A) today announced the launch of its Biopharma CDx Services Lab (BCSL) in Carpinteria, California, following receipt of California State clinical laboratory license and Clinical Laboratory Improvement Amendments (CLIA) certificate of compliance.
